Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
SK Hynix Stock Soars as AI Memory Demand Outlook Fuels Chip Rally 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Yaskawa Electric Shares Slide as Weak Profit Overshadows Strong AI Demand 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
Rio Tinto Reports Strong Q2 Iron Ore Sales, Maintains 2026 Production Outlook 
Stellantis Q2 Vehicle Shipments Rise 10% as North America Drives Growth 
Samsung to Launch First Yongin Chip Plant by 2029 as South Korea Speeds Up Semiconductor Hub 
Nvidia Tightens AI Chip Sales in Asia With Stricter Customer Approval Process 
BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
SEB Q2 Profit Rises on Strong Lending, Record Fee Income, Announces New Share Buyback 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
UBS Starts CarTrade Tech With Buy Rating, Sees Strong Earnings Growth and ₹4,000 Target 
MONTPELLIER, France, Jan. 19, 2016 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, has announced the appointment of Teresa Prego to the position of Director of Marketing.
Based at Medtech’s U.S. branch, Ms. Prego will develop and implement the Company’s marketing policy, with a strong focus on supporting commercial operations in the U.S.. This includes the marketing strategy and commercial launch of the ROSA™ Spine robot in the U.S., which recently received 510K clearance from the U.S. Food and Drug Administration (FDA).
Ms. Prego has had more than 20 years of experience in strategic marketing within the medical field. Prior to Medtech, she served as a Senior Consultant at Andersen Consulting (now Accenture), held roles with Bayer, Boston Scientific, Aspect Medical and, most recently, was the Marketing Director at Tenet Healthcare.
“Teresa Prego’s marketing experience and expertise in the U.S. medical sector are major assets for Medtech,” said Bertin Nahum, CEO and Founder of Medtech. “Her appointment will contribute to driving adoption of our technology in various markets, including the launch of ROSA Spine in the U.S. True to the commitments we made at the time of the IPO, we are successfully executing on our growth strategy with additions to the management team to keep pace with the expansion of our commercial activity.”
| About MEDTECH | ||
| Founded in 2002 by Bertin NAHUM and based in Montpellier, MEDTECH is a European specialist in the design, development and marketing of innovative robotic appliances to assist surgeons during their medico-surgical interventions, thus contributing to the implementation of safer, more efficient, less-invasive treatment. In 2007, MEDTECH developed ROSA™, an innovative technological device devoted to brain surgery procedures. ROSA™ has been approved in Europe, the United States and Canada. In 2013 MEDTECH received the “European Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. In July 2014, MEDTECH obtained the CE marking for its new product ROSA™ Spine, a robotic- assistive device for minimally invasive surgery of the spine. In October 2014, MEDTECH won the “Révélation” prize in the Mediterranean Deloitte Technology Fast 50 Awards. In 2015 MEDTECH received the “2016 Company of the Year Award” in the “robotic neurosurgery” category from Frost & Sullivan. In November 2015, MEDTECH was honored by Deloitte In Extenso for its excellent performance in the Technology Fast 50 Mediterranean Awards, in the “listed company” category. In January 2016, MEDTECH obtained the FDA clearance for its new product, ROSA™ Spine, a robotic-assistive device for minimally invasive surgery of the spine. | ||
CONTACT MEDTECH Christophe Sibillin Chief Financial Officer Tel : +33 (0)4 67 10 77 40 INVESTORS Corinne Puissant Tel : +33 (0)1 53 67 36 77 [email protected] PRESS Alexandra Prisa (EU) Tel. : +33(0)1 53 67 36 90 [email protected] Joanna Zimmerman (US) Tel : +1 646-536-7006 [email protected]
